Financial Times FT.com

Resources

Chemical industry 2007

Inside this issue

• Private equity accounts for nearly half of last year’s record deals

• Implementation of EU emissions scheme faces a challenge

• The trend against joint chemicals and pharma groups - -

Content

A downturn looms larger

The Middle East and China are central to the sector’s fortunes, says Salamander Davoudi

Mergers and acquisitions: Deals hit a record high

Private equity buyers need to keep their nerve, says Salamander Davoudi

ICI: Ancestor of sector leaves rich legacy

Once a bellwether, the company still has a central role, says Salamander Davoudi

Sabic: Gulf group diversifies

The company wants to extend its reach into higher-value products, writes Salamander Davoudi

Johnson Matthey: Environment yields most growth

Drive toward cleaner transport boosts the specialist chemicals maker, write Cristina Jimenez and Salamander Davoudi

Green chemistry: Voluntary restraint is the target

Business can save money while lessening the need for legislation, says Sarah Murray

The environment: Doubt about regime

The EU emissions trading scheme is welcome – but not necessarily its implementation, says Fiona Harvey

Regulation: EU rules please no one

Battles over Reach legislation are about to restart, says Tobias Buck

UK is too quiet a success

Despite leading the way in carbon-cutting solutions, its chemical industry is not well-promoted, writes guest columnist Steve Elliott

Universities: Spin-outs put new life into the sector

Academics can claim many significant commercial successes, says Clive Cookson

Pharmaceuticals: Two arms turn into one

Public relations: Image is in need of a revamp

Recruitment: War for talent heats up in new markets